ArticleComputational and structural biotechnology journal2025
"intelligent Read Across (iRA)"- A tool for read-across-based toxicity prediction of nanoparticles.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid advancement of nanotechnology has enabled the use of nanoparticles (NPs) in various applications, such as medicine, electrochemical sensors, and cosmetics, due to their unique physical and chemical properties. Their small size allows these particles to penetrate biological systems and interact with intracellular components, which may pose significant health risks to humans and other organisms. As a result, assessing the health risks and environmental impacts of NPs has gained considerable attention. Experimental evaluation of NP toxicity is resource-intensive and raises ethical issues; therefore, various computational methods are used for toxicity assessments. In this research, we introduce a Python-based tool called "intelligent Read Across (iRA)," which makes predictions using similarity-based read-across algorithms. In addition to toxicity endpoint predictions, this tool enables pairwise similarity calculations, read-across optimization, and the identification of important features related to read-across predictions. Similarity calculations assess how close compounds are based on their molecular descriptors. The read-across optimization feature helps determine the best hyperparameter values for the similarity measures. Furthermore, feature importance analysis evaluates the relative significance of features involved in read-across prediction. This tool has been validated using three small datasets (≤ 30 samples) containing nanotoxicity data. External validation metrics show improvements over previously reported models across all datasets. These results demonstrate the effectiveness of this similarity-based read-across method. Consequently, the developed tool can be used for accurate prediction of the toxic potential and prioritization of data-poor NPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.